Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.02 USD | +1.01% | +1.01% | -28.85% |
May. 30 | Monte Rosa Therapeutics Names Three Insiders to Leadership Team | MT |
May. 30 | Monte Rosa Therapeutics, Inc. Announces Executive Promotions | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.85% | 246M | |
+49.41% | 56.95B | |
+39.44% | 40.26B | |
-6.72% | 39.32B | |
-5.96% | 28.37B | |
+12.99% | 26.45B | |
-19.82% | 19.41B | |
+32.35% | 12.54B | |
-0.08% | 12.15B | |
+25.18% | 12.21B |
- Stock Market
- Equities
- GLUE Stock
- News Monte Rosa Therapeutics, Inc.
- UBS Adjusts Monte Rosa Therapeutics Price Target to $20 From $22, Maintains Buy Rating